BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/29/2014 5:50:00 PM | Browse: 1159 | Download: 1362
Publication Name World Journal of Transplantation
Manuscript ID 13214
Country United States
Received
2014-08-12 17:16
Peer-Review Started
2014-08-12 19:25
To Make the First Decision
2014-08-28 14:55
Return for Revision
2014-09-01 10:43
Revised
2014-10-09 00:00
Second Decision
2014-10-29 18:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-29 18:58
Articles in Press
2014-10-29 18:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-12-15 16:31
Publish the Manuscript Online
2014-12-29 17:46
ISSN 2220-3230 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Minireviews
Article Title Role of liver transplantation in the management of hepatoblastoma in the pediatric population
Manuscript Source Invited Manuscript
All Author List Saira Khaderi, Jacfranz Guiteau, Ronald T Cotton, Christine O’Mahony, Abbas Rana and John A Goss
Funding Agency and Grant Number
Corresponding Author Saira Khaderi, MD, MPH, Assistant Professor of Surgery, Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 6620 Main Street, Suite 1425, Houston, TX 77030, United States. khaderi@bcm.edu
Key Words Liver transplant; Hepatoblastoma; Pediatric; Chemotherapy; Cancer
Core Tip Hepatoblastoma (HB) is the most common primary liver tumor in children. Between one-third to two-thirds of patients present with unresectable tumors or distant metastases, but up to 85% of these tumors become operable after neoadjuvant chemotherapy. Liver transplantation is the only treatment option for unresectable HB. In 2010 the pediatric end-stage liver disease scoring system began to award additional “exception” points for patients with HB. We analyzed the Standard Transplant Analysis and Research dataset and found that patients who were listed for transplantation with current HB exception criteria experienced a shorter waitlist time but survival was similar between the two eras.
Publish Date 2014-12-29 17:46
Citation Khaderi S, Guiteau J, Cotton RT, O’Mahony C, Rana A, Goss JA. Role of liver transplantation in the management of hepatoblastoma in the pediatric population. World J Transplant 2014; 4(4): 294-298
URL http://www.wjgnet.com/2220-3230/full/v4/i4/294.htm
DOI http://dx.doi.org/10.5500/wjt.v4.i4.294
Full Article (PDF) WJT-4-294.pdf
Full Article (Word) WJT-4-294.doc
Manuscript File 13214-Review.docx
Answering Reviewers 13214-Answering reviewers.pdf
Copyright License Agreement 13214-Copyright assignment.pdf
Peer-review Report 13214-Peer review(s).pdf
Scientific Misconduct Check 13214-CrossCheck.jpg
Scientific Editor Work List 13214-Scientific editor work list.pdf